REG - PureTech Health PLC - Transaction in Own Shares
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240202:nRSB7833Ba&default-theme=true
RNS Number : 7833B PureTech Health PLC 02 February 2024
2 February 2024
PureTech Health plc
Transaction in Own Shares
PureTech Health PLC (the "Company") announces that it has purchased the
following number of its ordinary shares of one pence each through Jefferies
International Limited ("Jefferies"), as part of its Share Buyback Programme,
details of which were announced on 9 May 2022.
Date of purchase: 1 February 2024
Number of ordinary shares purchased: 87,581
Highest price paid per share: 198.00p
Lowest price paid per share: 194.40p
Volume weighted average price paid per share: 197.26p
PureTech intends to retain the purchased shares in treasury.
Following the above transaction, the Company will have 19,288,866 ordinary
shares in treasury and has 270,179,293 ordinary shares in issue (excluding
treasury shares). The total number of voting rights in the Company is
therefore 270,179,293 which may be used by shareholders in their calculations
to determine if they are required to notify their interest in, or a change to
their interest in, PureTech Health plc under the FCA's Disclosure Guidance and
Transparency Rules.
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (as
incorporated into UK domestic law by the European Union (Withdrawal) Act 2018)
(the Market Abuse Regulation), detailed information about the individual
purchases is available below.
About PureTech Health
PureTech is a clinical-stage biotherapeutics company dedicated to giving life
to new classes of medicine to change the lives of patients with devastating
diseases. The Company has created a broad and deep pipeline through its
experienced research and development team and its extensive network of
scientists, clinicians and industry leaders that is being advanced both
internally and through its Founded Entities. PureTech's R&D engine has
resulted in the development of 27 therapeutics and therapeutic candidates,
including two (Plenity® and EndeavorRx®) that have received both U.S.
FDA clearance and European marketing authorization and a third (KarXT) that
has been filed for FDA approval. A number of these programs are being advanced
by PureTech or its Founded Entities in various indications and stages of
clinical development, including registration enabling studies. All of the
underlying programs and platforms that resulted in this pipeline of
therapeutic candidates were initially identified or discovered and then
advanced by the PureTech team through key validation points.
For more information, visit www.puretechhealth.com
(http://www.puretechhealth.com/) or connect with us on X, formerly known as
Twitter, @puretechh.
Contact:
PureTech
Investor Relations
IR@puretechhealth.com
Individual Transactions
Transaction Date Transaction Time Volume Price (GBp) Platform Transaction Reference Number
01/02/2024 12:49:28 238 197.2 AQXE 00388179512TRLO0.1.1
01/02/2024 12:49:28 492 197.2 BATE 00388179513TRLO0.1.1
01/02/2024 12:49:28 122 197.2 CHIX 00388179514TRLO0.1.1
01/02/2024 12:49:28 34 197.2 CHIX 00388179515TRLO0.1.1
01/02/2024 12:49:28 336 197.2 CHIX 00388179516TRLO0.1.1
01/02/2024 12:49:28 17 197 XLON 00388179517TRLO0.1.1
01/02/2024 12:49:28 482 197 XLON 00388179518TRLO0.1.1
01/02/2024 12:49:28 977 197 XLON 00388179519TRLO0.1.1
01/02/2024 12:49:28 956 197 XLON 00388179520TRLO0.1.1
01/02/2024 12:49:28 12 197.2 CHIX 00388179521TRLO0.1.1
01/02/2024 12:49:28 264 197.2 CHIX 00388179522TRLO0.1.1
01/02/2024 12:56:46 14948 198 XLON 00388180931TRLO0.1.1
01/02/2024 12:56:46 1014 198 XLON 00388180932TRLO0.1.1
01/02/2024 12:56:46 3057 198 XLON 00388180933TRLO0.1.1
01/02/2024 12:56:46 413 198 XLON 00388180935TRLO0.1.1
01/02/2024 12:56:46 427 198 XLON 00388180934TRLO0.1.1
01/02/2024 12:56:46 238 198 XLON 00388180936TRLO0.1.1
01/02/2024 12:56:46 6991 198 XLON 00388180937TRLO0.1.1
01/02/2024 12:56:49 395 198 CHIX 00388180967TRLO0.1.1
01/02/2024 12:57:39 492 197.8 XLON 00388181171TRLO0.1.1
01/02/2024 12:57:44 433 197.8 CHIX 00388181223TRLO0.1.1
01/02/2024 13:01:14 390 197.8 XLON 00388181854TRLO0.1.1
01/02/2024 13:04:17 200 197.8 XLON 00388182273TRLO0.1.1
01/02/2024 13:10:22 141 197.8 XLON 00388183333TRLO0.1.1
01/02/2024 13:12:21 32 197.8 CHIX 00388183524TRLO0.1.1
01/02/2024 13:18:25 12 197.8 CHIX 00388184519TRLO0.1.1
01/02/2024 13:20:01 82 197.2 AQXE 00388184801TRLO0.1.1
01/02/2024 13:20:01 974 197.8 XLON 00388184802TRLO0.1.1
01/02/2024 13:20:40 116 197.8 CHIX 00388184908TRLO0.1.1
01/02/2024 13:28:08 530 197.8 XLON 00388186264TRLO0.1.1
01/02/2024 13:28:22 145 197.8 CHIX 00388186274TRLO0.1.1
01/02/2024 14:21:14 316 198 AQXE 00388196735TRLO0.1.1
01/02/2024 14:21:16 275 198 BATE 00388196750TRLO0.1.1
01/02/2024 14:27:58 15 198 XLON 00388198391TRLO0.1.1
01/02/2024 14:27:58 3218 198 XLON 00388198392TRLO0.1.1
01/02/2024 14:27:58 829 198 XLON 00388198393TRLO0.1.1
01/02/2024 14:27:58 3709 198 XLON 00388198394TRLO0.1.1
01/02/2024 14:27:58 326 198 XLON 00388198395TRLO0.1.1
01/02/2024 14:29:39 492 198 XLON 00388198824TRLO0.1.1
01/02/2024 14:30:10 204 198 CHIX 00388199838TRLO0.1.1
01/02/2024 14:31:38 492 198 XLON 00388200849TRLO0.1.1
01/02/2024 14:33:04 196 198 CHIX 00388201543TRLO0.1.1
01/02/2024 14:33:25 492 198 XLON 00388201837TRLO0.1.1
01/02/2024 14:35:10 492 198 XLON 00388202509TRLO0.1.1
01/02/2024 14:36:57 492 198 XLON 00388203280TRLO0.1.1
01/02/2024 14:38:39 492 198 XLON 00388204143TRLO0.1.1
01/02/2024 14:40:25 58 198 XLON 00388204676TRLO0.1.1
01/02/2024 14:40:25 434 198 XLON 00388204677TRLO0.1.1
01/02/2024 14:42:11 492 198 XLON 00388205483TRLO0.1.1
01/02/2024 14:43:54 492 198 XLON 00388206212TRLO0.1.1
01/02/2024 14:45:39 492 198 XLON 00388207628TRLO0.1.1
01/02/2024 14:46:24 172 198 CHIX 00388208954TRLO0.1.1
01/02/2024 14:47:26 492 198 XLON 00388210812TRLO0.1.1
01/02/2024 14:49:09 492 198 XLON 00388212446TRLO0.1.1
01/02/2024 14:50:53 271 198 XLON 00388213609TRLO0.1.1
01/02/2024 14:50:53 221 198 XLON 00388213610TRLO0.1.1
01/02/2024 14:52:17 33 198 CHIX 00388214402TRLO0.1.1
01/02/2024 14:52:42 492 198 XLON 00388214639TRLO0.1.1
01/02/2024 14:54:26 492 198 XLON 00388215504TRLO0.1.1
01/02/2024 14:56:17 492 198 XLON 00388216433TRLO0.1.1
01/02/2024 14:57:52 492 198 XLON 00388217391TRLO0.1.1
01/02/2024 14:59:36 492 198 XLON 00388218269TRLO0.1.1
01/02/2024 15:00:47 492 197.4 CHIX 00388219360TRLO0.1.1
01/02/2024 15:00:47 492 197.4 BATE 00388219361TRLO0.1.1
01/02/2024 15:00:47 128 197.4 TRQX 00388219363TRLO0.1.1
01/02/2024 15:00:47 492 197.4 BATE 00388219362TRLO0.1.1
01/02/2024 15:00:47 238 197.4 AQXE 00388219364TRLO0.1.1
01/02/2024 15:00:47 128 197.4 TRQX 00388219365TRLO0.1.1
01/02/2024 15:00:47 2460 197.4 XLON 00388219367TRLO0.1.1
01/02/2024 15:00:47 238 197.4 AQXE 00388219366TRLO0.1.1
01/02/2024 15:04:02 204 197.2 AQXE 00388221481TRLO0.1.1
01/02/2024 15:04:02 492 197 CHIX 00388221482TRLO0.1.1
01/02/2024 15:04:04 492 197 XLON 00388221486TRLO0.1.1
01/02/2024 15:04:11 837 197.4 BATE 00388221610TRLO0.1.1
01/02/2024 15:16:45 204 196.8 AQXE 00388227468TRLO0.1.1
01/02/2024 15:28:03 238 196.8 AQXE 00388231685TRLO0.1.1
01/02/2024 15:28:03 492 196.8 BATE 00388231686TRLO0.1.1
01/02/2024 15:28:03 492 196.8 BATE 00388231687TRLO0.1.1
01/02/2024 15:28:03 492 196.8 XLON 00388231688TRLO0.1.1
01/02/2024 15:28:03 492 196.8 XLON 00388231689TRLO0.1.1
01/02/2024 15:28:03 492 196.8 XLON 00388231690TRLO0.1.1
01/02/2024 15:28:03 492 196.8 XLON 00388231691TRLO0.1.1
01/02/2024 15:28:03 128 196.6 TRQX 00388231692TRLO0.1.1
01/02/2024 15:33:30 2 197.2 XLON 00388233796TRLO0.1.1
01/02/2024 15:33:30 244 196.6 AQXE 00388233797TRLO0.1.1
01/02/2024 15:48:37 492 196.6 BATE 00388239073TRLO0.1.1
01/02/2024 15:48:37 492 196.6 CHIX 00388239074TRLO0.1.1
01/02/2024 15:48:37 128 196.6 TRQX 00388239076TRLO0.1.1
01/02/2024 15:48:37 492 196.6 CHIX 00388239075TRLO0.1.1
01/02/2024 15:48:37 646 196.6 XLON 00388239077TRLO0.1.1
01/02/2024 15:48:37 1322 196.6 XLON 00388239078TRLO0.1.1
01/02/2024 15:48:37 982 196.6 XLON 00388239079TRLO0.1.1
01/02/2024 15:48:43 297 196.4 XLON 00388239242TRLO0.1.1
01/02/2024 15:48:43 80 196.4 XLON 00388239243TRLO0.1.1
01/02/2024 15:48:45 841 196.6 BATE 00388239286TRLO0.1.1
01/02/2024 15:54:22 36 195.8 CHIX 00388241733TRLO0.1.1
01/02/2024 15:54:22 70 195.8 BATE 00388241734TRLO0.1.1
01/02/2024 15:54:22 422 195.8 BATE 00388241735TRLO0.1.1
01/02/2024 15:54:22 456 195.8 CHIX 00388241736TRLO0.1.1
01/02/2024 15:54:22 492 195.8 CHIX 00388241737TRLO0.1.1
01/02/2024 15:54:22 129 195.8 XLON 00388241738TRLO0.1.1
01/02/2024 15:54:22 600 195.8 XLON 00388241739TRLO0.1.1
01/02/2024 15:54:22 142 195.8 XLON 00388241740TRLO0.1.1
01/02/2024 15:54:22 2081 195.8 XLON 00388241741TRLO0.1.1
01/02/2024 15:54:23 446 195.8 CHIX 00388241746TRLO0.1.1
01/02/2024 15:54:25 512 196.4 TRQX 00388241769TRLO0.1.1
01/02/2024 15:57:44 607 196.4 XLON 00388243873TRLO0.1.1
01/02/2024 15:58:41 325 196.4 XLON 00388244587TRLO0.1.1
01/02/2024 15:59:54 121 196.4 XLON 00388245243TRLO0.1.1
01/02/2024 16:00:35 19 196 CHIX 00388245587TRLO0.1.1
01/02/2024 16:00:35 34 196 CHIX 00388245588TRLO0.1.1
01/02/2024 16:00:35 439 196 CHIX 00388245589TRLO0.1.1
01/02/2024 16:00:35 2460 196 XLON 00388245590TRLO0.1.1
01/02/2024 16:00:39 266 195.6 AQXE 00388245621TRLO0.1.1
01/02/2024 16:00:39 93 195.6 AQXE 00388245622TRLO0.1.1
01/02/2024 16:00:39 19 195.6 AQXE 00388245623TRLO0.1.1
01/02/2024 16:08:32 370 196 XLON 00388249147TRLO0.1.1
01/02/2024 16:13:05 7 195.4 AQXE 00388251343TRLO0.1.1
01/02/2024 16:13:05 58 195.4 CHIX 00388251344TRLO0.1.1
01/02/2024 16:13:05 301 195.4 XLON 00388251345TRLO0.1.1
01/02/2024 16:18:44 348 195.4 CHIX 00388254913TRLO0.1.1
01/02/2024 16:18:44 86 195.4 CHIX 00388254914TRLO0.1.1
01/02/2024 16:18:44 65 195.4 TRQX 00388254916TRLO0.1.1
01/02/2024 16:18:44 63 195.4 TRQX 00388254915TRLO0.1.1
01/02/2024 16:18:44 499 195.4 XLON 00388254917TRLO0.1.1
01/02/2024 16:18:44 94 195 BATE 00388254919TRLO0.1.1
01/02/2024 16:18:44 230 195.4 XLON 00388254918TRLO0.1.1
01/02/2024 16:18:44 370 195.4 XLON 00388254920TRLO0.1.1
01/02/2024 16:18:44 122 195.4 XLON 00388254921TRLO0.1.1
01/02/2024 16:18:44 160 195 BATE 00388254922TRLO0.1.1
01/02/2024 16:18:44 478 195.4 XLON 00388254923TRLO0.1.1
01/02/2024 16:18:44 14 195.4 XLON 00388254924TRLO0.1.1
01/02/2024 16:18:44 586 195.4 XLON 00388254925TRLO0.1.1
01/02/2024 16:18:44 55 195.4 XLON 00388254926TRLO0.1.1
01/02/2024 16:18:44 106 195.4 XLON 00388254927TRLO0.1.1
01/02/2024 16:18:44 288 195.2 XLON 00388254928TRLO0.1.1
01/02/2024 16:18:48 17 195 BATE 00388254967TRLO0.1.1
01/02/2024 16:18:48 20 195 BATE 00388254968TRLO0.1.1
01/02/2024 16:18:48 10 195 BATE 00388254969TRLO0.1.1
01/02/2024 16:18:50 25 195 BATE 00388254995TRLO0.1.1
01/02/2024 16:18:51 73 195 BATE 00388255004TRLO0.1.1
01/02/2024 16:19:00 76 195 BATE 00388255081TRLO0.1.1
01/02/2024 16:19:38 13 195 XLON 00388255413TRLO0.1.1
01/02/2024 16:19:38 213 195 XLON 00388255414TRLO0.1.1
01/02/2024 16:21:37 419 195 CHIX 00388256485TRLO0.1.1
01/02/2024 16:21:39 1300 194.8 XLON 00388256519TRLO0.1.1
01/02/2024 16:21:39 55 194.8 XLON 00388256520TRLO0.1.1
01/02/2024 16:21:39 442 194.8 XLON 00388256521TRLO0.1.1
01/02/2024 16:22:18 15 194.4 TRQX 00388256852TRLO0.1.1
01/02/2024 16:28:04 508 195.4 XLON 00388259835TRLO0.1.1
01/02/2024 16:29:17 984 195.4 XLON 00388260529TRLO0.1.1
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END POSFLFETFRILIIS
- Announcement
- Announcement
- Announcement
- Announcement
- Announcement